MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    A Case of Neurodegeneration with Brain Iron Accumulation with novel Adaptor Protein-4 M1 subunit mutation

    A. Battineni, D. Vijayakumar (Greenville, USA)

    Objective: To present a patient with clinical and radiological features of neurodegeneration with brain iron accumulation (NBIA) due to a novel variant mutation in adaptor…
  • 2022 International Congress

    Olfactory Network Reorganization in Parkinson’s Disease

    L. Pesantez Pacheco, M. Saqib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

    Objective: To explore changes in the organization and functionality of the olfactory network in patients with Parkinson’s Disease (PD) using graph theory-based network analysis on…
  • 2022 International Congress

    Oro-bucco-lingual dyskinesia as a side effect of methotrexate therapy

    H. Sarac, F. Borovecki, I. Sarac, N. Henigsberg (Zagreb, Croatia)

    Objective: to demonstrate association between the tardive dyskinesia and methotrexate therapy. Background: Dystonia is found among patients taking methotrexate. However, methotrexate and tardive oro-bucco-lingual dyskinesia…
  • 2022 International Congress

    Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Retrocollis Subtype of Cervical Dystonia

    K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)

    Objective: To describe characteristics and treatment response to onabotulinumtoxinA (onabotA) of patients with retrocollis (RC). Background: The CD-PROBE trial of onabotA included patients with RC,…
  • 2022 International Congress

    Discrimination in Healthcare for Parkinsonism Across Sexual and Gender Minority Groups

    E. Bayram, K. Wyman-Chick, L. Damron, I. Litvan (La Jolla, USA)

    Objective: To compare perceived discrimination in healthcare across men, women and LBGTQ+ people with parkinsonism Background: Stigma, often experienced by people with parkinsonism and care…
  • 2022 International Congress

    Efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease patients with motor fluctuations: a multicenter randomized open-label cross-over trial

    HJ. Chang, J. Park, S. Oh, CW. Shin, JW. Cho, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to assess the efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease (PD) patients with motor fluctuation. Background: Delayed…
  • 2022 International Congress

    Clinical, environmental, and Technology-based gait measures in PD patients from a rural area in southwestern Colombia: a case-control pilot study

    B. Muñoz-Ospina, H. Clavijo-Moran, D. álvarez-García, A. Navarro Cadavid, I. F Mata, J. Orozco Velez (Cali, Colombia)

    Objective: Describe the clinical characteristics, environmental exposures, and technology-based gait assessment of a sample of Parkinson’s disease patients in a rural area in southwestern of…
  • 2022 International Congress

    Factors that negatively impact the sexual function of men living with Parkinson’s disease

    B. de Souza (São Paulo, Brazil)

    Objective: To investigate the impact of motor, non-motor function, and relationship quality on sexual function in men living with PD. Background: Among the non-motor alteration…
  • 2022 International Congress

    Sleep-wake disturbance in Creutzfeldt-Jakob disease mimicking fatal familial insomnia

    T. Thammongkolchai, A. Charoensri, S. Liamsombut, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a patient with sleep-wake disturbance mimicking fatal familial insomnia Background: Sleep disturbances are well recognized in fatal familial insomnia (FFI) which is…
  • 2022 International Congress

    Different longitudinal manifestations in dopaminergic dysfunction in REM sleep behavior disorder

    P. Wu, H. Yu (Shanghai, China)

    Objective: To explore the different patterns of dopaminergic dysfunction between iRBD patients who convert to Parkinson’s disease (PD)/dementia with Lewy bodies (DLB) and those who…
  • « Previous Page
  • 1
  • …
  • 90
  • 91
  • 92
  • 93
  • 94
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley